Current Scenario and Future Prospect in the Management of COVID-19-Reference-Cited by-同舟云学术

Current Scenario and Future Prospect in the Management of COVID-19

Published:2020-12-30 Issue:2 Volume:28 Page:284-307
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Borah Pobitra¹^ORCID,Deb Pran Kishore²^ORCID,Deka Satyendra¹^ORCID,Venugopala Katharigatta N.³^ORCID,Singh Vinayak⁴^ORCID,Mailavaram Raghu Prasad⁵^ORCID,Kalia Kiran⁶^ORCID,Tekade Rakesh Kumar⁶^ORCID

Affiliation:

1. Pratiksha Institute of Pharmaceutical Sciences, Chandrapur Road, Panikhaiti, Guwahati-781026, Assam, India

2. Department of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, PO Box 1, Amman 19392, Jordan

3. Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia

4. Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch, 7701, South Africa

5. Department of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Vishnupur, Bhimavaram – 534 202, West Godavari Dist., Andhra Pradesh, India

6. National Institute of Pharmaceutical Education and Research– Ahmedabad (NIPER-A), Opposite Air Force Station Palaj, Gandhinagar-382355, Gujarat, India

Abstract

: The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk assessment, rapid spreading ability, and propensity to precipitate severe disease in comorbid conditions. In an attempt to fulfill the demand for prophylactic and treatment measures to intercept the ongoing outbreak, the drug development process is facing several obstacles and renaissance in clinical trials, including vaccines, antivirals, immunomodulators, plasma therapy, and traditional medicines. This review outlines the overview of SARS-CoV-2 infection, significant recent findings, and ongoing clinical trials concerning current and future therapeutic interventions for the management of advancing pandemic of the century.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference99 articles.

1. World Health Organization Coronavirus Disease (COVID-19) - events as they happen

2. Jin Y.; Yang H.; Ji W.; Wu W.; Chen S.; Zhang W.; Duan G.; virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 2020,12(4),372

3. Guo Y-R.; Cao Q-D.; Hong Z-S.; Tan Y-Y.; Chen S-D.; Jin H-J.; Tan K-S.; Wang D-Y.; Yan Y.; The Origin, Transmission and clinical therapies on coronavirus disease 2019 (COVID-19) Outbreak-an Update on the Status. Mil Med Res 2020,7(1),1-10

4. Coutard B.; Valle C.; de Lamballerie X.; Canard B.; Seidah N.G.; Decroly E.; The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020,176

5. Tang X.; Wu C.; Li X.; Song Y.; Yao X.; Wu X.; Duan Y.; Zhang H.; Wang Y.; Qian Z.; On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev 2020

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress of Fluorescent Carbon Dots and Graphene Quantum Dots for Biosensors: Synthesis of Solution Methods and their Medical Applications;Journal of Fluorescence;2024-06-13

2. Drug Therapies against Acute Respiratory Distress: A Critical Endpoint of COVID-19;Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19;2023-11-02

3. Exploring the Chemical Reactivity andBioactivity of Romidepsin: A CDFT-BasedComputational Peptidology Study;2023-11-01

4. Antiviral drugs and vaccines;Medicinal Chemistry of Chemotherapeutic Agents;2023

5. Heterocyclic compounds as antimicrobial agents;Viral, Parasitic, Bacterial, and Fungal Infections;2023